POST 00910E : VACCINE WASTAGE

Follow-up on Posts 00889E, 00894E, 00899E and 00906E

11 April 2006

This posting contains a contribution from Sridharan Rangachari
(mailto:[email protected]) from India.

I fully agree with Anthony's view:

"The quantity of Hepatitis B vaccine "wasted" by Nigeria in 2004 would be
enough to meet the needs of all the adjacent countries plus Togo, Guinea
Bissau, Burkina Faso and Central African Republic."

When I was with PATH in India, I tried my level best through my project
activities to market HBV in Uniject by two Indian companies. One could
succeed in the Urban market but felt it is a long way to go for promoting
this in the international area.

PATH has proved by a study in Indonesia that by marketing HBV in Uniject
the wastage can be considerably reduced.

What is the current standing of UNICEF on getting HBV in Uniject? If
UNICEF can offer a good price, maybe we can influence the Indian company
to promote the same!

Any thoughts?

Thanks,

Sridharan

Sridharan Rangachari,
Pharmaceutical & Regulatory Adviser,
Consultant:

QMS :ISO 9001-2000

Visit the TECHNET21 Website at http://www.technet21.org

You will find instructions to subscribe, a direct access to archives, links to reference documents and other features.

To UNSUBSCRIBE,
send a message to : mailto:[email protected]
Leave the subject area BLANK
In the message body, write unsubscribe TECHNET21E

The World Health Organization and UNICEF support TechNet21. The TechNet21 e-Forum is a communication/information tool for generation of ideas on how to improve immunization services. It is moderated by Claude Letarte and is hosted in cooperation with the Centre de internationale en sant, Canada (http://www.ccisd.org)